Till startsida
Sitemap

News

  • The most effective surgical procedure for extreme obesity should be used with caution

    [6 Feb 2015] Based on five-year follow-up of patients in a randomized clinical trial, researchers have concluded that gastric bypass is the preferred treatment for extreme obesity despite the fact that it is not as effective in reducing body weight as duodenal switch.

  • Web method can prevent blindness in premature babies

    [29 Jan 2015] Children born prematurely are at risk of being struck by the eye disease ROP, which can cause blindness. Using a new web-based method, doctors can now identify the at-risk children long before the initial symptoms present themselves, which increases the possibility of preventive measures.

  • Swedish model for PSA testing has little effect on mortality

    [21 Jan 2015] The spontaneous PSA testing that has been applied in Sweden in recent decades has only had a marginal effect on mortality. An organized screening focused on those who have the most to gain would, however, reduce the risk of dying from prostate cancer by over 40 percent. This is shown by studies at the Sahlgrenska Academy.

  • Researchers find hormone that increases the sex drive of mice

    [20 Jan 2015] Swedish studies show that mice that receive a supplement of the "appetite hormone" ghrelin increase their sexual activity. Whether the hormone has the same impact on humans is unknown - but if it does, the researchers may have found the key to future treatments for sex abuse.

  • Portable stimulator being tested on Parkinson patients

    [19 Jan 2015] Researchers at the Sahlgrenska Academy have shown that a weak electric "noise" can improve balance and motor skills in patients with Parkinson´s disease. In cooperation with NASA, the research team has now developed a portable prototype that will be used in long-term studies of Parkinson´s patients in their home environment.

More news

Media contacts


Krister Svahn
Press Officer
at Sahlgrenska Academy
Mobile: +46 766 18 38 69
Phone: +46 31 786 3869

To the top